EUVIMEDEUVIMED entdecken
Crossref

Serum Angiopoietin-2 Levels Predict the Development of Hepatocellular Carcinoma following Hepatitis C Virus Eradication Using Direct-Acting Antiviral Agents

Takanori Suzuki, Kentaro Matsuura, Yoshihito Nagura, Hayato Kawamura, Kei Fujiwara, Shintaro Ogawa, Katsuya Nagaoka, Etsuko Iio, Takehisa Watanabe, Hiromi Kataoka, Yasuhito Tanaka

Oncology · 2024

DOI: 10.1159/000536154 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology, 2024. Verfasst von Takanori Suzuki und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Antiviral Agents, Angiopoietin-2. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Our previous studies showed that serum angiopoietin-2 (Ang-2) and C-X-C motif chemokine ligand 10 (CXCL10) levels predicted improvement in liver fibrosis following sustained virological response (SVR) of hepatitis C virus (HCV) obtained with administration of with direct-acting antiviral agents (DAAs). These levels were evaluated retrospectively as predictive indicators of hepatocellular carcinoma (HCC) development following SVR.

Methods

We enrolled individuals from a historical cohort of 89 chronic HCV patients without history of HCC at baseline and with SVR following DAA therapy and had baseline serum levels of Mac-2 binding protein glycosylation isomer ≥2.0 cut-off index (C.O.I.).

Results

Multivariate analyses revealed that only the Ang-2 level at 24 weeks following the end of treatment (EOT24W) was significantly related to HCC development (hazard ratio 2.27; p = 0.003). This result was reproduced in individuals without history of HCC and with advanced liver fibrosis (M2BPGi level ≥3.3 C.O.I. at baseline). Time-dependent receiver operating characteristic curve analyses for the future risk of developing HCC within 5 years of follow-up (5y-HCC) showed the best cut-off Ang-2 level at the EOT24W was 2,780 pg/mL, and significantly stratified the cumulative incidence of HCC (≥2,780 vs. < 2,780 pg/mL, 5y-HCC: 45.5 vs. 8.2%, p < 0.001).

Conclusions

At the EOT24W, serum Ang-2 level predicts the likelihood of developing HCC following SVR to DAA therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsAntiviral AgentsAngiopoietin-2Hepatitis C, ChronicHumansMaleFemaleMiddle AgedRetrospective StudiesAgedSustained Virologic ResponseLiver CirrhosisHepacivirusAdultBiomarkers, Tumor

Stichwörter der Autor:innen

Angiopoietin-2C-X-C motif chemokine ligand 10Hepatocellular carcinoma

Substanzen

Antiviral AgentsAngiopoietin-2ANGPT2 protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
  • Department of Gastroenterology, Kasugai Municipal Hospital, Kasugai, Japan.
  • Department of Gastroenterology and Hepatology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.

Zitieren

APA

Suzuki, T., Matsuura, K., Nagura, Y., Kawamura, H., Fujiwara, K., Ogawa, S., Nagaoka, K., Iio, E., Watanabe, T., Kataoka, H., & Tanaka, Y. (2024). Serum Angiopoietin-2 Levels Predict the Development of Hepatocellular Carcinoma following Hepatitis C Virus Eradication Using Direct-Acting Antiviral Agents. Oncology. https://doi.org/10.1159/000536154

Vancouver

Suzuki T, Matsuura K, Nagura Y, Kawamura H, Fujiwara K, Ogawa S, et al. Serum Angiopoietin-2 Levels Predict the Development of Hepatocellular Carcinoma following Hepatitis C Virus Eradication Using Direct-Acting Antiviral Agents. Oncology. 2024. doi:10.1159/000536154

BibTeX
@article{Suzuki2024,
  author = {Suzuki, Takanori and Matsuura, Kentaro and Nagura, Yoshihito and Kawamura, Hayato and Fujiwara, Kei and Ogawa, Shintaro and Nagaoka, Katsuya and Iio, Etsuko and Watanabe, Takehisa and Kataoka, Hiromi and Tanaka, Yasuhito},
  title = {Serum Angiopoietin-2 Levels Predict the Development of Hepatocellular Carcinoma following Hepatitis C Virus Eradication Using Direct-Acting Antiviral Agents},
  journal = {Oncology},
  year = {2024},
  doi = {10.1159/000536154}
}
Kostenlos starten →